Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
₹9 Cr
P/E Ratio
24.9
P/B Ratio
0.99
Industry P/E
66.84
Debt to Equity
0.24
ROE
12.52 %
ROCE
15.31 %
Div. Yield
0 %
Book Value
21.12
EPS
2.21
CFO
₹--
EBITDA
₹--
Net Profit
₹--
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Clinitech Laboratory
| -48.64 | -34.03 | -42.14 | -- | -- | -- | -- |
|
BSE Healthcare*
| -7.68 | 6.11 | -2.04 | 19.11 | 18.77 | 22.70 | 8.84 |
|
BSE Small Cap#
| -12.49 | 9.35 | -8.34 | 5.55 | 17.55 | 35.38 | 15.06 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 800.90 | 2,592.38 | 34.26 | 9.17 | |
| 1,662.60 | 8,524.97 | 56 | 13.35 | |
| 708.60 | 3,757.24 | 42.83 | 17.29 | |
| 1,040.70 | 10,710.61 | 75.49 | 20.53 |
No Review & Analysis are available.
--
Incorporated
2010
Chairman
Jagdish Umakant Nayak
Managing Director
Jagdish Umakant Nayak
Headquarters
Thane, Maharashtra
Website
Looking for more details about Clinitech Laboratory Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Clinitech Laboratory Ltd stood at ₹ 6 Cr as on 31-Mar-24
The share price of Clinitech Laboratory Ltd is ₹40.50 (BSE) as of 11-Apr-2025 IST. Clinitech Laboratory Ltd has given a return of --% in the last 1 years.
Clinitech Laboratory Ltd has a market capitalisation of ₹ 9 Cr as on 11-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Clinitech Laboratory Ltd is 0.99 times as on 11-Apr-2025, a 87% discount to its peers’ median range of 7.39 times.
The P/E ratio of Clinitech Laboratory Ltd is 24.90 times as on 11-Apr-2025, a 63% discount to its peers’ median range of 66.84 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Clinitech Laboratory Ltd and enter the required number of quantities and click on buy to purchase the shares of Clinitech Laboratory Ltd.
The prominent promoters of Clinitech Laboratory Ltd are
| Name of promoters | Holding percentage |
|---|---|
|
JYOTI JAGDISH NAYAK |
29.57%
|
|
JAGDISH UMAKANT NAYAK |
29.55%
|
|
SIDDHESH ANANT NAYAK |
2.43%
|
The chairman of the company is Jagdish Umakant Nayak, and the managing director is Jagdish Umakant Nayak.
There is no promoter pledging in Clinitech Laboratory Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
9,897
|
|
|
8,224
|
|
|
3,725
|
|
|
2,405
|
| Clinitech Laboratory Ltd | Ratios |
|---|---|
|
Return on equity(%)
|
12.52
|
|
Operating margin(%)
|
8.78
|
|
Net Margin(%)
|
5.76
|
|
Dividend yield(%)
|
--
|
Yes, TTM profit after tax of Clinitech Laboratory Ltd was ₹0 Cr.
₹0.50
(
